Downregulation of miR-503 Promotes ESCC Cell Proliferation,Migration,and Invasion by Targeting Cyclin D1

被引:5
|
作者
Lanfang Jiang [1 ]
Zitong Zhao [1 ]
Leilei Zheng [1 ]
Liyan Xue [1 ]
Qimin Zhan [1 ]
Yongmei Song [1 ]
机构
[1] State Key Laboratory of Molecular Oncology,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College
基金
中国国家自然科学基金;
关键词
Esophageal squamous cell carcinoma; miR-503; Cyclin D1; Proliferation; Migration and invasion;
D O I
暂无
中图分类号
R735.1 [食管肿瘤];
学科分类号
摘要
Esophageal squamous cell carcinoma(ESCC) is one of the most aggressive cancers in China,but the underlying molecular mechanism of ESCC is still unclear.Involvement of microRNAs has been demonstrated in cancer initiation and progression.Despite the reported function of miR-503 in several human cancers,its detailed anti-oncogenic role and clinical significance in ESCC remain undefined.In this study,we examined miR-503 expression by q PCR and found the downregulation of miR-503 expression in ESCC tissue relative to adjacent normal tissues.Further investigation in the effect of miR-503 on ESCC cell proliferation,migration,and invasion showed that enhanced expression of miR-503 inhibited ESCC aggressive phenotype and overexpression of CCND1 reversed the effect of miR-503-mediated ESCC cell aggressive phenotype.Our study further identified CCND1 as the target gene of miR-503.Thus,miR-503 functions as a tumor suppressor and has an important role in ESCC by targeting CCND1.
引用
收藏
页码:208 / 217
页数:10
相关论文
共 50 条
  • [1] Downregulation of miR-503 Promotes ESCC Cell Proliferation, Migration, and Invasion by Targeting Cyclin D1
    Jiang, Lanfang
    Zhao, Zitong
    Zheng, Leilei
    Xue, Liyan
    Zhan, Qimin
    Song, Yongmei
    GENOMICS PROTEOMICS & BIOINFORMATICS, 2017, 15 (03) : 208 - 217
  • [2] miR-503 inhibits cell proliferation and invasion in glioma by targeting L1CAM
    Liu, Hao
    Song, Zhi
    Liao, Daguang
    Zhang, Tianyi
    Liu, Feng
    Zheng, Wen
    Luo, Kui
    Yang, Liang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (10): : 18441 - 18447
  • [3] Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1
    Ye, Jin
    Li, Laisheng
    Feng, Pinning
    Wan, Jianxin
    Li, Jingjia
    ONCOLOGY REPORTS, 2016, 36 (01) : 390 - 398
  • [4] LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer
    Wang, Lu
    Tang, Lei
    Ge, Tengfei
    Zhu, Feng
    Liu, Dan
    Guo, Hua
    Qian, Peng
    Xu, Ning
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [5] LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer
    Lu Wang
    Lei Tang
    Tengfei Ge
    Feng Zhu
    Dan Liu
    Hua Guo
    Peng Qian
    Ning Xu
    BMC Pulmonary Medicine, 21
  • [6] MiR-503 promotes the migration and invasion of colorectal cancer cells by regulating PDCD4
    Li, Lihua
    Zhang, Xiaolian
    Yi, Zengxing
    Liang, Xiaofang
    Yin, Weihua
    Li, Shaoyuan
    JOURNAL OF BUON, 2018, 23 (03): : 579 - 586
  • [7] Long noncoding RNA SNHG7 accelerates prostate cancer proliferation and cycle progression through cyclin D1 by sponging miR-503
    Qi, Honggang
    Wen, Bifeng
    Wu, Qihang
    Cheng, Wei
    Lou, Jiangyong
    Wei, Junjun
    Huang, Jianjun
    Yao, Xuping
    Weng, Guobin
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 102 : 326 - 332
  • [8] MiR-503 suppresses cell proliferation and invasion of gastric cancer by targeting HMGA2 and inactivating WNT signaling pathway
    Wenjing Li
    Jun Li
    Hong Mu
    Meiqi Guo
    Haixia Deng
    Cancer Cell International, 19
  • [9] MiR-503 suppresses cell proliferation and invasion of gastric cancer by targeting HMGA2 and inactivating WNT signaling pathway
    Li, Wenjing
    Li, Jun
    Mu, Hong
    Guo, Meiqi
    Deng, Haixia
    CANCER CELL INTERNATIONAL, 2019, 19 (1)
  • [10] miR-373 promotes neuroblastoma cell proliferation, migration, and invasion by targeting SRCIN1
    Yuan, Xiu-Li
    Wen, Fei-Qiu
    Chen, Xiao-Wen
    Jiang, Xian-Ping
    Liu, Si-Xi
    ONCOTARGETS AND THERAPY, 2019, 12 : 4927 - 4936